Medifast (MED) Leases (2019 - 2026)

Medifast (MED) has 8 years of Leases data on file, last reported at $12.9 million in Q1 2026.

• For the quarter ending Q1 2026, Leases rose 29.08% year-over-year to $12.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (up 29.08% YoY), and the FY2025 full-year result was $7.2 million, down 35.17% from the prior year.
• Leases for Q1 2026 stood at $12.9 million, up from $7.2 million in the prior quarter.
• Across five years, Leases topped out at $22.9 million in Q1 2022 and bottomed at $7.2 million in Q4 2025.
• The 5-year median for Leases is $14.5 million (2024), against an average of $14.5 million.
• The widest annual swing landed in 2022, when Leases soared 138.41%; it then plunged 35.17% in 2025.
• A 5-year view of Leases shows it stood at $18.5 million in 2022, then slipped by 15.25% to $15.6 million in 2023, then dropped by 28.7% to $11.2 million in 2024, then slumped by 35.17% to $7.2 million in 2025, then soared by 78.66% to $12.9 million in 2026.
• The last three Leases figures came in at $12.9 million (Q1 2026), $7.2 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.

Peer Comparison